Ipriflavone

CAS NO.: 35212-22-7
Molecular Formula: C18H16O3
Molecular Weight: 280.323
Appearance: White powder

Function
1. Bone Health: Ipriflavone has been studied for its potential to improve bone density and reduce the risk of fractures, especially in postmenopausal women.
2. Osteoporosis: Ipriflavone has been investigated as a treatment for osteoporosis, a condition characterized by weak and brittle bones.
3. Hormone Regulation: Isoflavones, including ipriflavone, are known to have estrogenic properties. They can bind to estrogen receptors and exert estrogen-like effects in the body.
4. Anti-inflammatory Effects: Some research has indicated that ipriflavone may possess anti-inflammatory properties.

Description About Ipriflavone
Ipriflavone is a synthetic isoflavone derivative that has been used as a dietary supplement mainly for its potential benefits in bone health. It is structurally similar to the natural isoflavones found in soybeans and other legumes.
Ipriflavone gained attention as a potential treatment for osteoporosis, a condition characterized by low bone density and an increased risk of fractures. It was believed to work by inhibiting bone breakdown and promoting bone formation.
It can significantly inhibit the decline of bone density, bone strength and caltropin. It also has the effects of increasing bone mass, promoting thyroid calcium secretion and inhibiting the number of osteoclasts. It is also used to treat osteoporosis.
Its anti-osteoporosis mechanism is:
1. Promote the proliferation of osteoblasts, promote collagen synthesis and bone matrix mineralization, and increase bone mass;
2. Reduce the proliferation and differentiation of osteoclast precursor cells, inhibit the activity of mature osteoclasts, and reduce bone resorption;
3. It increases the secretion of calcitonin through estrogen-like effects and indirectly produces anti-bone resorption effects;